Immunology, oncology, rheumatology, neurology, ophthalmology: today's pipelines are infusion-delivered, and sponsors, CROs, and site networks are competing for the patients already in your chairs. Trial IQ matches protocols against your patient records and brings the trials to your centers, with the support to run them.
A WeInfuse partner · read the announcement
Illustrative — we run a real analysis for your network
In our network, with data covering diagnoses, treatment histories, labs, and chart notes.
Computed against actual protocol criteria, so opportunities are real, not speculative.
Matched to your patient population, your chair capacity, and your locations.
A secure connection brings your patient population onto the platform, under your governance, with your data staying yours.
Your centers, capabilities, and chair capacity are profiled so sponsors, CROs, and site networks searching for infusion-capable sites can find your network.
Staff education, research readiness, training management, regulatory setup, and trial workflows: supported end to end, no research department required first.
Matched opportunities flow to you. You engage your own patients, trials run in your chairs, and research revenue lands on infrastructure you own.
Sponsors don't struggle with the science. They struggle to find infusion-capable sites that actually have the matching patients.
Standing up a research operation from scratch means years of hiring, sponsor-chasing, and empty pipelines. On the platform, matching is done for you: opportunities arrive scoped to patients you already treat, and you choose which to accept.
Today, patients who want trial access enroll at academic centers, and their infusion revenue follows them out the door. Opting in lets you offer the therapies in today's pipelines from your own chairs, deepening care relationships instead of losing them.
Your network is exactly the infrastructure modern trials require, and the platform is how sponsors, CROs, and site networks find it. Every protocol matched to your patient mix, your chair capacity, and your locations.
Sponsors and CROs pay for the research. You pay nothing. Trials bring revenue to your center, and the platform, matching, and readiness support that get you there are free.
Trials run in the chairs and hours you allocate. The opportunity analysis accounts for your chair capacity up front, and you accept only protocols that fit your census, so research fills spare capacity rather than crowding out standard-of-care infusions.
Nothing. Sponsors and CROs fund the research, Trial IQ is paid on the sponsor side, and trial revenue lands on the infrastructure you already own. You never pay for the platform, the matching, or the readiness support.
You do. The connection is governed by a BAA and scoped to what matching requires, and matched patients are identified to your center alone: how to engage them is your decision. Sponsors never see patient identities before consent, and disconnecting is always your call.
With a conversation. Tell us about your centers below, and our team walks you from where you stand today to first protocol: profiling, training, and regulatory setup included.
Still have questions? Reach out to us here.
Tell us about your centers and we'll show you which actively enrolling and upcoming trials your patient population already qualifies for: center by center.